I am new on this board and have only posted a few times, but have read most of the posts since June.
CT Medic question, in the M/M study while small provided evidence of a reduction of SAEs of 60% i believe it was. So if LL was combined with something like Dex or any of the other drugs during the initial viral phase of Covid, couldn't LL provide a dual benefit of aiding in the reduction of advancement to S/C and also be used to treat S/C should the disease progress to that state?
I understand supply is limited, but i would have to believe if OWS wanted, they could throw $XXXM at this and seek to produce more with 2 of the Manufactures that Cytodyn has worked with.